©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2014; 20(44): 16714-16720
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16714
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16714
Table 1 Patient characteristics
| Variables | n = 78 |
| Age (yr) | 66.7 ± 10.3 |
| Gender (male/female) | 63/15 |
| HBs-Ag (+/-) | 26/52 |
| HCV-Ab (+/-) | 21/57 |
| Alcohol abuse (+/-) | 10/68 |
| NASH (+/-) | 14/64 |
| Diabetes mellitus (+/-) | 25/73 |
| Hyperlipidemia (+/-) | 18/60 |
| Platelets (× 104/mm3) | 16.6 ± 7.0 |
| Prothrombin time (INR) | 1.05 ± 0.11 |
| Albumin (g/dL) | 4.0 ± 0.6 |
| Total bilirubin (mg/dL) | 0.8 ± 0.3 |
| Cholinesterase (U/L) | 248 ± 70 |
| Tumor size (cm) | 49.6 ± 36.9 |
| Tumor number | 1.2 ± 0.5 |
| Tumor vascular invasion (+/-) | 21/57 |
| Ishak classification 0/1/2/3/4/5/6 | 14/11/8/18/4/13/10 |
| MELD score | 5.3 ± 1.3 |
| CTP score | 5.2 ± 0.2 |
| ICG R15 (%) | 11.6 ± 6.0 |
- Citation: Taniguchi M, Okizaki A, Watanabe K, Imai K, Uchida K, Einama T, Shuke N, Miyokawa N, Furukawa H. Hepatic clearance measured with 99mTc-GSA single-photon emission computed tomography to estimate liver fibrosis. World J Gastroenterol 2014; 20(44): 16714-16720
- URL: https://www.wjgnet.com/1007-9327/full/v20/i44/16714.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i44.16714